Nestle Health Science will buy the rights to Seres Therapeutics’ Vowst, the companies said, gaining access to the first ever pill alternative to fecal transplants for a deadly infection.
Tag Archive for: infection
Given the need for Rebyota in the market, Ferring’s launch training strategy focused on high-engagement learning through a unique learning journey that empowered its commercial teams to appropriately educate providers on the product features, benefits, and applications. This article walks through how the company and its partners created an immersive product launch learning experience for the field team built upon an engaging and strategic curriculum and a user-friendly training and event platform.
Global health officials have repeatedly warned about the rise of antimicrobial-resistant microbes due to the misuse and overuse of antibiotics, which encourages microorganisms to evolve into “superbugs.”
The outbreak of Marburg virus infection in Equatorial Guinea has ended, the World Health Organization’s regional office for Africa said on Thursday.
If approved, the combo vaccine could simplify the immunization schedule in the United States and likely expand GSK’s already dominant market share there for vaccines used to prevent illnesses caused by meningococcal bacteria.
The head of the panel of 18 appointees, known as STIKO, said there was no clear case for broad use, citing a lack of data to rule out any rare side effects and no signs of the infection causing severe illness in otherwise healthy children.
A rebound of COVID-19 symptoms in some patients after taking Pfizer’s antiviral Paxlovid may be related to a robust immune response rather than a weak one, U.S. government researchers reported on Thursday.
In an interview, WHO senior adviser Bruce Aylward warned that richer nations must not step back from tackling COVID-19 as a global problem now, ahead of future potential waves of infection.
Vaccine developers have universally failed to translate any effective S. aureus vaccine from mice to humans. Researchers now understand why prior attempts failed and – importantly – what they need to do to develop an S. aureus vaccine that is effective in humans.